论文部分内容阅读
Past and current trials of the RTOG/NRG Oncology GI Committee Targeted therapy, personalized therapy
【机 构】
：
GI Section Department of Radiation Oncology MD Anderson Cancer Center
【出 处】
：
中华医学会第九次全国放射肿瘤治疗学学术会议
【发表日期】
：
2012年11期
其他文献
Objective To study pharmacology and toxicology of extracts from Arcangelisia gusanlung H.S.Lo.Methods The anti-inflammatory activities were tested using various inflammatory models including ear swell
The Pregnane X receptor (PXR) is an orphan nuclear receptor and plays a pivotal role in the activation of human cytochrome P450 3A4 (CYP3A4) gene.Praeruptorin A (PA),praeruptorin C (PC) and praeruptor
Two New Natural Products from the Fruits of Alpinia oxyphylla with Inhibitory Effects on Nitric Oxid
Chemical investigation of the fruits of Alpinia oxyphylla led to the isolation of two new natural products,9-hydroxy epinootkatol (1),(S)-2-pentanol-2-O-β-D-glucopyranoside (2),in addition to nine kno
Crude dietary polysaccharide fraction isolated from Jackfruit and immune enhancement activity in mic
Ethnopharmacological relevance:The dietary fruit pulp of Jackfruit (Artocarpus heterophyllus Lam.;family Moraceae) is used as replenishing Qi (Yiqi) agent in traditional Chinese herb medicine (TCM).Ai
放射性肺损伤(RILI)是胸部肿瘤放疗的常见并发症，也是胸部肿瘤放疗的主要剂量限制性因素。溶血凝脂酸（LPA）是重要的磷脂信使分子，主要通过其5种受体发挥作用。本文研究LPA及其受体LPAR在放射性肺损伤病理进展过程中的作用机制，试图为临床放射性肺损伤的治疗寻找新的靶点。
本文介绍了胰腺癌治疗的现状及放疗技术的进展，分析了放射疗法剂量模式改变的意义，并进一步阐述了剂量模式改变的临床应用及结果。文章还探讨了现代放疗面临的挑战以及剂量模式改变治疗胰腺癌的展望。
Glioblastoma Multiforme:Preclinical and Clinical Research with RT and various agents, results from E
会议
Loco-regionally advanced esophageal cancer is a lethal disease with poor outcomes despite aggressive multimodality therapy.Surgical resection has been considered as the standard of care.The surgical m
会议